BACLOFEN
| Brand name | OZOBAX |
|---|---|
| Active ingredient | BACLOFEN |
| Strength | 5MG/5ML |
| Dosage form | SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | September 2019 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 10610502 | August 2039 | use U-2779 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.